Fundraising FoxPromptly
3 known investors
Find your way into Promptly
Sign up to see every warm intro you have to Promptly
- Paths you didn't know you had: your email and LinkedIn already hold routes to the Promptly team. We find them for you
- 2nd- and 3rd-degree connections: the friend-of-a-friend routes that take hours to manually find through your inbox or LinkedIn
- Answers now, not in days: momentum is everything in a raise. Skip asking around whether someone knows someone
Days of research, done the moment you sign in, with every route ranked by how warm it is.
Promptly generates real-world clinical evidence by harmonizing and sharing patient data—including clinical records, claims data, and patient-reported outcomes—for life sciences companies, insurers, and healthcare providers. The platform combines longitudinal patient data with digital biomarkers to enable evidence generation across multiple therapeutic areas and geographies.
Investors · 3
Nina Capitallisted by Nina CapitalBarcelona · $215K – $1.6M
How we know: the VCSheet dataset · Not right? Tell us
Frequently asked questions
- What does Promptly do?
- Promptly generates real-world clinical evidence by harmonizing and sharing patient data—including clinical records, claims data, and patient-reported outcomes—for life sciences companies, insurers, and healthcare providers. The platform combines longitudinal patient data with digital biomarkers to enable evidence generation across multiple therapeutic areas and geographies.
- Who are Promptly's investors?
- Promptly's investors include Kfund, Nina Capital, Shilling VC.